Durable disease control following multidisciplinary treatment including pembrolizumab in POLE-mutated dedifferentiated endometrial carcinoma with brain metastases

Takumi Ito, Jumpei Yoshida, Akari Iwakoshi, Keiji Sugiyama, Rieko Nishimura, Tomoko Inaba, Masashi Sanada, Chiyoe Kitagawa

Open source

DOI: 10.1097/md.0000000000050714
Published: 2026-09-18
Container: Medicine
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000050714,
  title = {Durable disease control following multidisciplinary treatment including pembrolizumab in POLE-mutated dedifferentiated endometrial carcinoma with brain metastases},
  author = {Takumi Ito and Jumpei Yoshida and Akari Iwakoshi and Keiji Sugiyama and Rieko Nishimura and Tomoko Inaba and Masashi Sanada and Chiyoe Kitagawa},
  year = {2026},
  journal = {Medicine},
  doi = {10.1097/md.0000000000050714},
  url = {https://doi.org/10.1097/md.0000000000050714}
}

RIS

TY  - JOUR
TI  - Durable disease control following multidisciplinary treatment including pembrolizumab in POLE-mutated dedifferentiated endometrial carcinoma with brain metastases
AU  - Takumi Ito
AU  - Jumpei Yoshida
AU  - Akari Iwakoshi
AU  - Keiji Sugiyama
AU  - Rieko Nishimura
AU  - Tomoko Inaba
AU  - Masashi Sanada
AU  - Chiyoe Kitagawa
PY  - 2026
JO  - Medicine
DO  - 10.1097/md.0000000000050714
UR  - https://doi.org/10.1097/md.0000000000050714
ER  -

APA

Ito, T., Yoshida, J., Iwakoshi, A., Sugiyama, K., Nishimura, R., Inaba, T., Sanada, M., & Kitagawa, C. (2026). Durable disease control following multidisciplinary treatment including pembrolizumab in POLE-mutated dedifferentiated endometrial carcinoma with brain metastases. Medicine. https://doi.org/10.1097/md.0000000000050714

Source records

crossref · retrieved 2026-09-26T11:01:59.164Z